Daniel Lustenberger joins KetoSwiss AG

​

KetoSwiss welcomes Daniel Lustenberger as Financial, Business & Strategy Advisor.

First patent got all claims approved

​

A huge step towards the product protection, we will keep you posted.

Dr. Sebastian Hersberger joins KetoSwiss AG

​

The KetoSwiss team is enriched by Sebastian, an expert in business development and financial management, who joins KetoSwiss AG as Chief Operating Officer. Welcome!

KetoSwiss completes Seed Funding round

​

KetoSwiss raised CHF 0.5 million in a first seed funding round.

Dr. Egle B. Thomas joins KetoSwiss AG

​

Dr. Egle B. Thomas joins KetoSwiss AG as Business & Strategy Advisor. Welcome!

Final product (MigraKet4) developed

​

Looking back at 4 years of development, KetoSwiss AG has finalised its product. In a next step, clinical trials will be conducted - we keep you posted.

KetoSwiss extents its portfolio to Alzheimer's

​

In addition to migraine, KetoSwiss will clinical test the efficacy of its lead product in Alzheimer's Disease with the first randomised controlled trial starting in summer 2019.

Swiss Innovation Challenge

​

KetoSwiss achieved 5th place at the Swiss Innovation Challenge.

Swiss Innovation Challenge participation

​

KetoSwiss is taking part in the Swiss Innovation Challenge and made it to the second round - we keep you posted.

First pharmacokinetic trial completed

​

The first PK trial on healthy subjects has been completed, the second is starting soon.